|
(MoneyNewsWire.Net, February 12, 2016 )
Mexico Genetic Testing Market Outlook to 2021
Summary
GlobalDatas new report, "Mexico Genetic Testing Market Outlook to 2021", provides key market data on the Mexico Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.
The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.
To Browse a Full Report with TOC: http://www.researchmoz.us/mexico-genetic-testing-market-outlook-to-2021-report.html
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
Scope
- Genetic Testing market includes Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Genetic Testing market.
- Global corporate-level profiles of key companies operating within the Mexico Genetic Testing market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Danaher Corporation, Abbott Laboratories, Hologic, Inc., Cepheid, Bio-Rad Laboratories, Inc., Qiagen N.V., Transgenomic, Inc. and PerkinElmer, Inc.
1.1 List of Tables
Table 1: Genetic Testing Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 8
Table 2: Genetic Testing Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Table 3: Genetic Testing Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2013-2014 11
Table 4: Genetic Testing Market, Mexico, Company Share by Revenue ($m), USD Constant, 2014 13
Table 5: Genetic Testing Market Pipeline Products 17
Table 6: Genomic Vision Extends Agreement with Quest Diagnostics 21
Table 7: Hibergene Diagnostics Enters into Licensing Agreement with Eiken for LAMP 23
1.2 List of Figures
Figure 1: Genetic Testing Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 7
Figure 2: Genetic Testing Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 9
Figure 3: Genetic Testing Market, Mexico, Company Share (%) 2014 12
To Download Sample Report With TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=483418
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948
Email: sales@researchmoz.us
WebSite:http://www.researchmoz.us/
Blog: http://industryresearchnews.blogspot.com
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
|
